Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan 3;3(1):1.
doi: 10.1186/2191-219X-3-1.

Nuclear imaging of inflammation: homing-associated molecules as targets

Affiliations

Nuclear imaging of inflammation: homing-associated molecules as targets

Anu Autio et al. EJNMMI Res. .

Abstract

The golden standard in nuclear medicine imaging of inflammation is the use of autologous radiolabeled leukocytes. Although their diagnostic accuracy is precise, the preparation of the leukocytes is both laborious and potentially hazardous for laboratory personnel. Molecules involved in leukocyte migration (homing-associated molecules) could serve as targets for the development of imaging agents for inflammation. An excellent target would be a molecule that is absent or expressed at low levels in healthy tissues, but is present or upregulated at the sites of inflammation. In this paper, we will review the literature concerning the use of homing-associated molecules as imaging targets. We will especially concentrate on vascular adhesion protein-1 due to the promising results regarding its use as a target for the imaging of inflammation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
VAP-1 targeting imaging agents in detecting inflammation. (a) PET images of 68Ga-labeled VAP-1 binding peptides in a rat model of sterile skin/muscle inflammation. All the images fall within the same radioactivity scale and the scale bar is shown on the left. (b) Inflammation-to-muscle ratios obtained from PET imaging at 60 min after injection.

Similar articles

Cited by

References

    1. Boerman OC, Rennen H, Oyen WJ, Corstens FH. Radiopharmaceuticals to image infection and inflammation. Semi Nucl Med. 2001;31:286–295. doi: 10.1053/snuc.2001.26189. - DOI - PubMed
    1. Gotthardt M, Bleeker-Rovers CP, Boerman OC, Oyen WJ. Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques. J Nucl Med. 2010;51:1937–1949. doi: 10.2967/jnumed.110.076232. - DOI - PubMed
    1. Rahmim A, Zaidi H. PET versus SPECT: strengths, limitations and challenges. Nucl Med Commun. 2008;29:193–207. doi: 10.1097/MNM.0b013e3282f3a515. - DOI - PubMed
    1. Love C, Tomas MB, Tronco GG, Palestro CJ. FDG PET of infection and inflammation. Radiographics. 2005;25:1357–1368. doi: 10.1148/rg.255045122. - DOI - PubMed
    1. Vos FJ, Bleeker-Rovers CP, Corstens FH, Kullberg BJ, Oyen WJ. FDG-PET for imaging of non-osseous infection and inflammation. Q J Nucl Med Mol Imaging. 2006;50:121–130. - PubMed

LinkOut - more resources